AzTrials
AzTrials

Pelvic Floor DisorderNCT07429539

Psychosocial Skills Group for Pelvic Floor Symptoms

A study testing Education and Psychosocial Skills in people with Pelvic Floor Disorder and Pelvic Floor Awareness, run by Dartmouth-Hitchcock Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

There is a critical need for evidence-based programs that address the educational needs and psychosocial impact of childbirth-related pelvic floor injuries and conditions in an accessible format. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Pelvic Floor Disorder, Pelvic Floor Awareness
What is being tested?
Education and Psychosocial Skills
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited States
Study dates
17 Feb 2026to 19 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

None listed.

Who cannot join

  • Cognitive disability that prevents participants from understanding and engaging with spoken and written group content
  • Suicidal thoughts or urges to harm oneself
  • Lack of private space to join the group sessions from
  • Current pregnancy

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshire, 03766

Other trials in United States

About this study

Official title: Piloting a Virtual Education and Psychosocial Skills Group for Postpartum Pelvic Floor Symptoms

There is a critical need for evidence-based programs that address the educational needs and psychosocial impact of childbirth-related pelvic floor injuries and conditions in an accessible format. The purpose of this pilot study is to develop, implement, and evaluate the feasibility, acceptability, and preliminary effectiveness of a manualized 6-session psychosocial skills and education group for individuals with birth-related pelvic floor injuries and conditions. This group-based approach integrates psychoeducation, pain science, cognitive-behavioral techniques, acceptance-based and mindfulness skills to enhance quality of life and coping skills for those managing these conditions.

This research study will test whether a virtual education and psychosocial skills group can provide valuable resources and skill-building for people living with these conditions. The findings from this pilot study will help us understand whether this type of program is feasible, acceptable, and potentially beneficial, and will inform refinement of the group protocol and study procedures in preparation for a future randomized controlled trial.

Being tested
Education and Psychosocial Skills
Keywords
childbirth injuries, pelvic floor conditions
Medical subject headings
Pelvic Floor Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Education and Psychosocial SkillsBehavioural

    Participants will attend a 6-session, virtual psychosocial education and skills group, for individuals with birth-related pelvic floor conditions. This is a non-randomized pilot feasibility study. All enrolled participants will receive the same group content, with assessments conducted at baseline (pre-group), brief surveys after each session, and immediately following group completion.

Study groups in NCT07429539
Study groupRoleWhat they receive
Education and Psychosocial Skills GroupExperimental6-session, virtual psychosocial education and skills group, for individuals with birth-related pelvic floor conditions
Receives: Behavioral: Education and Psychosocial Skills

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility - retention; number of participants who complete at least four out of six sessions

    Measured: Through study completion (average of 8 weeks)

  2. Feasibility - time to complete recruitment (target N=16)

    Measured: Through recruitment completion

  3. Feasibility of the Intervention Measure

    4-item instrument measuring the feasibility of an intervention using a 5-point Likert scale, with higher scores reflecting higher feasibility. Score range: 1-5 (score represents mean of items).

    Measured: Post-test administered immediately after completing 6-week intervention

  4. Acceptability - Participant ratings of content relevance and helpfulness

    Measured: Weekly for 6 weeks

  5. Acceptability of the Intervention Measure

    4-item instrument measuring the acceptability of an intervention using a 5-point Likert scale, with higher scores reflecting greater acceptability. Score range: 1-5 (score represents mean of items).

    Measured: Post-test administered immediately after completing 6-week intervention

Secondary outcomes (8)
  1. Patient Health Questionnaire

    9-item depression measure, with each item scored on a 4-point Likert scale. Score range: 0-27; higher scores reflect more severe depression symptoms.

    Measured: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

  2. Perinatal Anxiety Screening Scale

    31-item measure of perinatal anxiety, with each item scored on a 4-point Likert scale. Score range: 0-93; higher scores reflect more severe anxiety symptoms.

    Measured: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

  3. Barkin Index of Maternal Functioning

    20-item measure of maternal functioning, with each item scored on a 7-point Likert scale. Score range 0-120; higher total scores reflect higher functioning.

    Measured: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

  4. University of Washington Self-Efficacy Scale

    6-item measure of chronic condition-related self-efficacy, with each item scored on a 5-point Likert scale. Scores range from 6-30; higher scores reflect greater self-efficacy.

    Measured: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

  5. Pelvic Floor Impact Questionnaire

    21-item measure of pelvic floor symptom-related impact, with each item scored on a 4-point Likert scale. Validated scoring formula results in a total score range of 0-300; higher scores reflect more symptom-related quality of life impairment.

    Measured: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

  6. Queensland Female Pelvic Floor Questionnaire

    42-item measure of pelvic floor symptom severity and associated level of bother across four categories (bladder function, bowel function, prolapse symtoms, sexual function), with each item scored on a 4-point Likert scale. Scores for each domain range from 0-10; higher scores reflect greater symptom severity.

    Measured: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

  7. Brief COPE Inventory

    28-items measure of various coping strategies, each item scored on a 4-point Likert scale. Scale scores range from 1-4 (representing mean of items); higher scores on each subscale indicate greater use of that coping strategy.

    Measured: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

  8. Female Self Advocacy Scale

    Female Self-Advocacy in Cancer Survivorship Scale (language modified; cancer survivorship --> pelvic floor symptom management); 20-item measure of health-related self-advocacy, with each item scored on a 6-point Likert scale. Scores range from 20-120; higher scores reflect greater self-advocacy.

    Measured: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2026
  2. Study start17 Feb 2026
  3. Primary completion19 May 2026
  4. Study completion19 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07429539
Sponsor's protocol ID
STUDY02003254
Status last verified
May 2026
First submitted
21 Jan 2026
Last updated
28 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: De-identified data may be shared upon request, pending updated data sharing agreement forms.

Questions about this trial

What is this clinical trial studying?

A study testing Education and Psychosocial Skills in people with Pelvic Floor Disorder and Pelvic Floor Awareness, run by Dartmouth-Hitchcock Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility - retention; number of participants who complete at least four out of six sessions (time frame: Through study completion (average of 8 weeks)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in